151 related articles for article (PubMed ID: 15206533)
1. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
Tsong Y; Zhang JJ; Wang SJ
J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
[TBL] [Abstract][Full Text] [Related]
2. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
Tsong Y; Shen M
J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
[TBL] [Abstract][Full Text] [Related]
3. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
4. Sample size determination for a three-arm equivalence trial of normally distributed responses.
Chang YW; Tsong Y; Dong X; Zhao Z
J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
[TBL] [Abstract][Full Text] [Related]
5. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
Jennison C; Turnbull BW
Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
[TBL] [Abstract][Full Text] [Related]
6. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
[TBL] [Abstract][Full Text] [Related]
7. An approximate approach to sampling size determination for the equivalence hypothesis.
Hsieh CY; Liu JP
J Biopharm Stat; 2013 May; 23(3):526-38. PubMed ID: 23611193
[TBL] [Abstract][Full Text] [Related]
8. Optimization of testing times and critical values in sequential equivalence testing.
Müller HH; Schäfer H
Stat Med; 1999 Jul; 18(14):1769-88; discussion 1789. PubMed ID: 10407247
[TBL] [Abstract][Full Text] [Related]
9. Equivalence trials: methodologic analysis.
Carneiro A
Rev Port Cardiol; 2003 Sep; 22(9):1125-39. PubMed ID: 14655314
[TBL] [Abstract][Full Text] [Related]
10. A group sequential type design for three-arm non-inferiority trials with binary endpoints.
Li G; Gao S
Biom J; 2010 Aug; 52(4):504-18. PubMed ID: 20645389
[TBL] [Abstract][Full Text] [Related]
11. Pilot trial for the assessment of relative bioavailability in generic drug product development: statistical power.
Wang Y; Zhou S
J Biopharm Stat; 1999 Mar; 9(1):179-87. PubMed ID: 10091917
[TBL] [Abstract][Full Text] [Related]
12. Equivalence and noninferiority testing in regression models and repeated-measures designs.
Mascha EJ; Sessler DI
Anesth Analg; 2011 Mar; 112(3):678-87. PubMed ID: 21304155
[TBL] [Abstract][Full Text] [Related]
13. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
14. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
[TBL] [Abstract][Full Text] [Related]
15. On testing equivalence of three populations.
Wiens BL; Iglewicz B
J Biopharm Stat; 1999 Aug; 9(3):465-83. PubMed ID: 10473032
[TBL] [Abstract][Full Text] [Related]
16. United States Food and Drug Administration requirements for approval of generic drug products.
Meyer MC
J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
[TBL] [Abstract][Full Text] [Related]
17. The scope and requirements related to preclinical and clinical studies of a new medicinal product, including biotechnological and biosimilar products.
Brodniewicz-Proba T
Acta Pol Pharm; 2008; 65(6):641-5. PubMed ID: 19172845
[TBL] [Abstract][Full Text] [Related]
18. Planning and monitoring of equivalence studies.
Durrleman S; Simon R
Biometrics; 1990 Jun; 46(2):329-36. PubMed ID: 2194579
[TBL] [Abstract][Full Text] [Related]
19. A confirmatory strategy for therapeutic equivalence trials.
Kieser M
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
[TBL] [Abstract][Full Text] [Related]
20. An algorithm for the design of group sequential triangular tests for single-arm clinical trials with a binary endpoint.
McWilliams TP
Stat Med; 2010 Nov; 29(27):2794-801. PubMed ID: 20860065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
